We constructed an ROC curve to evaluate the predictive power of △ASM/W Follow-up-Baseline for normalization of HOMA-IR in subjects with insulin resistance at baseline (n=116), normalization of ALT in patients with elevated ALT at baseline (n=194) and △LFC reduction ≥30% in the entire cohort (n=256). Here, GPT is linked to Insulin resistance.